Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies.

When considering the place of cell-free DNA screening it is important to make explicit the additional and marginal costs of different screening strategies and the associated benefits. Under most assumptions the balance is favorable for Contingent screening.